Home
VRNA
VRNA News

Latest Verona Pharma plc (VRNA) News on January 19, 2025

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Investor's Business Daily

2 days ago

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Zacks

5 days ago

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

9 days ago

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

9 days ago

Roth Initiates Verona Pharma at Buy

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Simply Wall St.

9 days ago

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

9 days ago

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

MT Newswires

12 days ago

Verona Pharma to Report $36 Million in Q4 Net Product Revenue

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

GlobeNewswire

12 days ago

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

MT Newswires

2 months ago

Verona Pharma Insider Sold Shares Worth $1,176,360, According to a Recent SEC Filing

Verona Pharma Announces December 2024 Investor Conference Participation

GlobeNewswire

2 months ago

Verona Pharma Announces December 2024 Investor Conference Participation

MT Newswires

2 months ago

Verona Pharma Insider Sold Shares Worth $568,387, According to a Recent SEC Filing

MT Newswires

2 months ago

Verona Pharma Insider Sold Shares Worth $618,658, According to a Recent SEC Filing

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Simply Wall St.

2 months ago

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

GuruFocus.com

2 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

Verona Pharma to Present at Jefferies London Healthcare Conference

GlobeNewswire

2 months ago

Verona Pharma to Present at Jefferies London Healthcare Conference

MT Newswires

2 months ago

Verona Pharma's Q3 Loss Widens

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

3 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks

3 months ago

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks

3 months ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

Zacks

3 months ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

MT Newswires

3 months ago

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

MT Newswires

3 months ago

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

3 months ago

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Zacks

3 months ago

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

3 months ago

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

MT Newswires

4 months ago

Wells Fargo Initiates Verona Pharma at Overweight With $50 Price Target

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

GlobeNewswire

4 months ago

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

4 months ago

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

GuruFocus.com

4 months ago

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

GlobeNewswire

4 months ago

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

GuruFocus.com

5 months ago

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

Insider Monkey

5 months ago

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

MT Newswires

5 months ago

Verona Pharma Q2 Net Loss Widens

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Simply Wall St.

6 months ago

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

GlobeNewswire

6 months ago

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

6 months ago

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

MT Newswires

6 months ago

Canaccord Genuity Raises Verona Pharma's Price Target to $37 From $35, Maintains Buy Rating

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

Zacks

6 months ago

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

MT Newswires

7 months ago

Truist Securities Raises Price Target on Verona Pharma to $38 From $32, Maintains Buy Rating

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

Pharmaceutical Technology

7 months ago

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

Benzinga

7 months ago

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

Pharmaceutical Technology

7 months ago

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

MT Newswires

7 months ago

HC Wainwright Adjusts Price Target on Verona Pharma to $36 From $32, Maintains Buy Rating

MT Newswires

7 months ago

Update: Verona Pharma Gets FDA Nod for Pulmonary Disease Treatment; Shares Jump Premarket

MT Newswires

7 months ago

Verona Pharma Gets US FDA Approval for Ohtuvayre in Chronic Obstructive Pulmonary Disease

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

GlobeNewswire

7 months ago

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

Investor's Business Daily

7 months ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

7 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

7 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

7 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

7 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

7 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

7 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

7 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

7 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

Pharmaceutical Technology

8 months ago

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

GuruFocus.com

8 months ago

Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

Insider Monkey

8 months ago

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

MT Newswires

8 months ago

Verona Pharma Signs Financing Agreements for Up to $650 Million

MT Newswires

8 months ago

Verona Pharma Shares Decline After Q1 Loss Widens

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

GlobeNewswire

8 months ago

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

GlobeNewswire

9 months ago

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswire

9 months ago

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update

Andrew Fisher Joins Verona Pharma as General Counsel

GlobeNewswire

a year ago

Andrew Fisher Joins Verona Pharma as General Counsel

Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Verona Pharma plc (NASDAQ:VRNA) Q4 2023 Earnings Call Transcript

3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

Motley Fool

a year ago

3 Healthcare Stocks That Have Outperformed Nvidia Since 2022

GuruFocus.com

a year ago

Verona Pharma PLC Reports Fourth Quarter and Full Year 2023 Financial Results

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?

Simply Wall St.

a year ago

When Will Verona Pharma plc (NASDAQ:VRNA) Turn A Profit?

Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

GlobeNewswire

a year ago

Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Sylvamo Corporation (SLVM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

a year ago

Sylvamo Corporation (SLVM) Upgraded to Strong Buy: What Does It Mean for the Stock?

Michael Austwick Joins Verona Pharma as Non-Executive Director

GlobeNewswire

a year ago

Michael Austwick Joins Verona Pharma as Non-Executive Director

Best Momentum Stocks to Buy for January 26th

Zacks

a year ago

Best Momentum Stocks to Buy for January 26th

Earnings Preview: Hub Group (HUBG) Q4 Earnings Expected to Decline

Zacks

a year ago

Earnings Preview: Hub Group (HUBG) Q4 Earnings Expected to Decline

OFG Bancorp (NYSE:OFG) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

OFG Bancorp (NYSE:OFG) Q4 2023 Earnings Call Transcript

A Look At The Fair Value Of Formula One Group (NASDAQ:FWON.K)

Simply Wall St.

a year ago

A Look At The Fair Value Of Formula One Group (NASDAQ:FWON.K)

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

Northern Trust Celebrates Dr. Martin Luther King, Jr. by Giving Back

ACCESSWIRE

a year ago

Northern Trust Celebrates Dr. Martin Luther King, Jr. by Giving Back

Q3 Rundown: Bentley (NASDAQ:BSY) Vs Other Vertical Software Stocks

StockStory

a year ago

Q3 Rundown: Bentley (NASDAQ:BSY) Vs Other Vertical Software Stocks

Infinitum and Alliance Resource Partners, L.P. Announce Agreement to Bring Highly Efficient, Reliable Motor Technology to the Mining Industry

Business Wire

a year ago

Infinitum and Alliance Resource Partners, L.P. Announce Agreement to Bring Highly Efficient, Reliable Motor Technology to the Mining Industry

Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures

Simply Wall St.

a year ago

Verona Pharma plc's (NASDAQ:VRNA) latest 11% decline adds to one-year losses, institutional investors may consider drastic measures

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Zacks

a year ago

Zacks.com featured highlights Universal Stainless & Alloy, Lakeland, NGL Energy and Iovance

Next-Gen Wealth: 7 Stocks to Catapult You to Millionaire Status

InvestorPlace

a year ago

Next-Gen Wealth: 7 Stocks to Catapult You to Millionaire Status

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions

Business Wire

a year ago

Thoughtworks Looking Glass Report Spotlights Strategy, Security and Responsibility in AI Solutions

3 Stocks Set to Soar 68% to 200% Higher

InvestorPlace

a year ago

3 Stocks Set to Soar 68% to 200% Higher

Here’s How Viasat (VSAT) Rebounded From “Stupidly Cheap” Levels

Insider Monkey

a year ago

Here’s How Viasat (VSAT) Rebounded From “Stupidly Cheap” Levels

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) stock falls 7.4% in past week as three-year earnings and shareholder returns continue downward trend

Simply Wall St.

a year ago

Hannon Armstrong Sustainable Infrastructure Capital (NYSE:HASI) stock falls 7.4% in past week as three-year earnings and shareholder returns continue downward trend

Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

GlobeNewswire

a year ago

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital

3 Stocks That Could Be Monster Winners in 2024

Motley Fool

a year ago

3 Stocks That Could Be Monster Winners in 2024

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

Zacks

a year ago

Fluor Corporation and Align Technology have been highlighted as Zacks Bull and Bear of the Day

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

Zacks

a year ago

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2024

Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference

PR Newswire

a year ago

Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conference

Carter's (CRI) Continues to Focus on Pricing: Stock to Gain

Zacks

a year ago

Carter's (CRI) Continues to Focus on Pricing: Stock to Gain

Investing in Apollo Medical Holdings (NASDAQ:AMEH) five years ago would have delivered you a 99% gain

Simply Wall St.

a year ago

Investing in Apollo Medical Holdings (NASDAQ:AMEH) five years ago would have delivered you a 99% gain

12 Solar Energy Stocks Billionaires Are Piling Into

Insider Monkey

a year ago

12 Solar Energy Stocks Billionaires Are Piling Into

Top Stocks for December 2023

Investopedia

a year ago

Top Stocks for December 2023

Share on Social Networks: